DERMATITIS, ATOPIC

This study is testing an investigational drug called JNJ-95475939 to see if it can reduce the rash, severe itch, and pain of moderate to severe eczema (atopic dermatitis). About 256 adults with long-term, hard-to-treat eczema will receive either the drug, a placebo, or an approve…

This study is testing a new injectable drug called 611 in Chinese children and teenagers with moderate to severe atopic dermatitis (eczema). The main goals are to check if the drug is safe, how it moves through the body, and if it can reduce the severity of skin symptoms and itch…

This study is testing an investigational drug called lunsekimig, given as an injection under the skin, to see if it can help adults with moderate-to-severe atopic dermatitis (eczema). About 150 participants will receive one of three different dose levels or a placebo for 24 weeks…

This study is for people who have already been in a previous trial for an investigational eczema drug called amlitelimab. Its main goal is to check the long-term safety and see how well the drug continues to work for moderate to severe atopic dermatitis. About 1,663 participants …

This study is testing an experimental drug called BAT6026 for adults with moderate to severe eczema that hasn't responded well to standard creams and ointments. Researchers are comparing different doses against a placebo to see which works best and is safest. The main goal is to …

This study aims to see if a drug called amlitelimab can help people with moderate-to-severe eczema (atopic dermatitis) maintain clear skin over a full year. It includes over 1,500 participants aged 12 and older who previously responded well to the drug in earlier studies. The mai…

This study aims to understand how a new investigational drug for eczema, called amlitelimab, might change how the body processes other common medications. It involves about 23 adults with moderate-to-severe atopic dermatitis. Researchers will measure drug levels in the blood to s…

This study follows 858 eczema patients who are starting treatment with Dupixent in real-world settings. Researchers will track how patients use the medication, monitor its effectiveness over time, and collect safety information. The goal is to understand how this treatment works …